ArticleCase reports in oncology

Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma.

Tsukasa Narukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.